More Press Releases

View Older Stories View Newer Stories

Oct 20, 2025 07:03AM UK Competition and Markets Authority to Refer Proposed Merger of Shutterstock and Getty Images for Phase 2 Review
Oct 20, 2025 07:03AM Alto Neuroscience Announces $50 Million Private Placement Financing
Oct 20, 2025 07:00AM Amex Announces Filing of Updated PEA Technical Report for the Perron Gold Project
Oct 20, 2025 07:00AM PreveCeutical Provides Update on Plan of Arrangement with BioGene Therapeutics Inc.
Oct 20, 2025 07:00AM Surge Battery Metals Advances 2025 Drill Program; Leverages U.S. Critical Minerals Policy
Oct 20, 2025 07:00AM IAMGOLD Agrees to Acquire Northern Superior Consolidating a Premier Mining Jurisdiction
Oct 20, 2025 07:00AM RETRANSMISSION: Manganese X Energy Corp. Underscores Urgency to Establish North American Battery Materials Supply Chain Due to China's Recent Export Controls on Critical Minerals
Oct 20, 2025 07:00AM Prospector Defines Multiple Gold Trends at Skarn Ridge: Drilling Highlights Include: 61.45 g/t Au over 1.9m and 4.64 g/t Au over 10m; 2.97 g/t Au over 25m; and 141 g/t Au over 0.5m
Oct 20, 2025 07:00AM Denarius Metals Receives Approval of Final Permit at Its Zancudo Project in Colombia and Is Commencing Construction of Its 1,000 Tonnes per Day Processing Plant to Begin Operations in Second Quarter o
Oct 20, 2025 07:00AM Highway 50 Gold Corp. Expands Quito North Land Position and Advances Exploration at Nevada Projects
Oct 20, 2025 07:00AM Sparq Announces Development of Duo Microinverter
Oct 20, 2025 07:01AM Alto Neuroscience Announces Plans to Accelerate Development of ALTO-207 in Treatment Resistant Depression Following Successful Outcome from Recent FDA Meeting
Oct 20, 2025 07:01AM 1-800-Packouts offers expert guidance to help homeowners prepare for and recover from fires
Oct 20, 2025 07:01AM Heineken Holding N.V. reports transactions under its current share buyback programme
Oct 20, 2025 07:00AM Signify share repurchase period update
Oct 20, 2025 06:59AM IAMGOLD Signs Agreement to Acquire Mines D'Or Orbec Inc.
Oct 20, 2025 07:00AM Schouw & Co. share buy-back programme, week 42 2025
Oct 20, 2025 07:00AM Fortrea Announces Tender Offer for up to $75,744,000 Aggregate Purchase Price of Outstanding Debt
Oct 20, 2025 07:00AM Vivid Seats Announces Termination of Tax Receivable Agreement and Elimination of Dual-Class Stock Structure
Oct 20, 2025 07:00AM Waco Corporation Launches Next-Generation Digital Water Purifiers 'IFev' and 'Apollo' Series
Oct 20, 2025 07:00AM Driving the Future of School Bus Safety: First Student's HALO™ Technology Platform - Powered with Advanced AI Insights - Takes Center Stage at the NYSE
Oct 20, 2025 07:00AM Generate Capital Secures C$60 million Financing from Fiera Infrastructure Private Debt for Upcycle, as RNG Momentum Builds Across North America
Oct 20, 2025 07:00AM TIME Names AI Coach by Edthena a Best Invention of 2025
Oct 20, 2025 07:00AM Freightos Reports KPIs for Third Quarter of 2025 Exceeding Management Expectations
Oct 20, 2025 07:00AM Anecdotes Announces New Integration With AuditBoard to Bring Joint Customers Data-Driven Continuous GRC
Oct 20, 2025 07:00AM Five Star Franchising ranked No. 6 on MountainWest Capital Network's Utah 100 list for 2025
Oct 20, 2025 07:00AM Novo Nordisk to present new data in oral semaglutide 25 mg (Wegovy® in a pill*) and obesity pipeline at ObesityWeek® 2025
Oct 20, 2025 07:00AM Coral reaches a 500k monthly workflow milestone as revenues scale 8x
Oct 20, 2025 07:00AM CITY OF LONDON INVESTMENT GROUP PLC ("City of London" or "the Group" or "the Company" or "CLIG") TRADING UPDATE FOR THE QUARTER TO 30 SEPTEMBER 2025
Oct 20, 2025 07:00AM HanchorBio Showcases Pipeline Momentum with HCB101 and HCB301 Data Across Five Major Oncology Meetings in Q4 2025
Oct 20, 2025 07:00AM Humber River Health Celebrates 10-Year Anniversary of Wilson Site
Oct 20, 2025 07:00AM BioCryst to Report Third Quarter 2025 Financial Results on November 3
Oct 20, 2025 07:00AM SINTX Technologies Receives FDA Clearance for SINAPTIC® Foot & Ankle Implant System
Oct 20, 2025 07:00AM GoldMining Reports Initial Drill Results and Confirms Multiple New Mineralized Targets across São Jorge Project, Brazil
Oct 20, 2025 07:00AM Westbridge Renewable Energy to Present at the Planet MicroCap Showcase in Toronto
Oct 20, 2025 07:00AM BPGbio and Icahn School of Medicine at Mount Sinai Publish Landmark Study on the Living Human Brain, Unlocking New Molecular Insights Into Neurodegenerative Disease
Oct 20, 2025 07:00AM Replimune Announces FDA Acceptance of BLA Resubmission of RP1 for the Treatment of Advanced Melanoma
Oct 20, 2025 07:00AM Collective Mining Provides an Exploration Update: Significant Visual Mineralization Intersected in Expansion Drilling at Both the Guayabales and San Antonio Projects
Oct 20, 2025 07:00AM RideCo and the City of Albuquerque's Transit Department Launch Innovative New On-Demand Transit Service
Oct 20, 2025 07:00AM Harmony Whole Person Oral Healthcare Launches Integrated Oral Health Facility in Oakland
Oct 20, 2025 07:00AM Miri Technologies to Unveil New Resilient Internet Platform and Upgrades to X510 Bonding Router at NAB Show New York
Oct 20, 2025 07:00AM ST Engineering iDirect Announces General Availability of Intuition Ground System
Oct 20, 2025 07:00AM Andel Raises $4.5M for Its Employer-Supported Medication Marketplace
Oct 20, 2025 07:00AM Enanta Pharmaceuticals Presents New Data for Zelicapavir, its N-Protein Inhibitor, and EDP-323, its L-Protein Inhibitor, Both in Development for the Treatment of Respiratory Syncytial Virus (RSV) at I
Oct 20, 2025 07:00AM Tune in to Bloomberg TV on Saturday, October 25th to watch a New Episode of Advancements
Oct 20, 2025 07:00AM Glaukos Announces FDA Approval of Epioxa™
Oct 20, 2025 07:00AM Leap Therapeutics Presents Final Data from DeFianCe Study at ESMO 2025
Oct 20, 2025 07:00AM Fanatec Powers Sim Racers with Launch of Highly Anticipated Products at SimRacing Expo 2025
Oct 20, 2025 07:00AM Spanish Mountain Gold Initiates Ore Sorting Work on Gold Mineralization
Oct 20, 2025 07:00AM Iambic Shares Clinical Data from Ph1/1B Study of IAM1363, a Highly Selective Type-2 HER2 Inhibitor, Demonstrating Monotherapy Activity in Heavily Pretreated Patients with HER2 Alterations, at the 2025
View Newer Stories View Older Stories